| ASSET | QUARTER | % RETURN |
|---|---|---|
TKO (TKO) | Q1 2014 | 75.2% |
Neurocrine Biosciences (NBIX) | Q1 2014 | 73.68% |
Applied Opt (AAOI) | Q1 2014 | 65.79% |
Tower Semiconductor (TSEM) | Q1 2014 | 56.78% |
Arrowhead Pharmaceuticals (ARWR) | Q1 2014 | 52.74% |
Globalstar, Inc Common Stock (GSAT) | Q1 2014 | 50.57% |
Cytokinetics (CYTK) | Q1 2014 | 46.83% |
American Airlines (AAL) | Q1 2014 | 45.99% |
Lattice Semiconductor (LSCC) | Q1 2014 | 42.55% |
AngloGold Ashanti (AU) | Q1 2014 | 40.69% |
Tesla (TSLA) | Q1 2014 | 39.15% |
Corcept Therapeutics (CORT) | Q1 2014 | 35.4% |
Illumina (ILMN) | Q1 2014 | 34.56% |
Teva Pharma Industries Ltd ADR (TEVA) | Q1 2014 | 33.02% |
Royal Gold (RGLD) | Q1 2014 | 32.95% |
MasTec (MTZ) | Q1 2014 | 32.8% |
Skyworks Solutions (SWKS) | Q1 2014 | 32.58% |
Globus Medical (GMED) | Q1 2014 | 31.96% |
NXP Semiconductors (NXPI) | Q1 2014 | 31.57% |
Tyson Foods (TSN) | Q1 2014 | 31.55% |
Texas Pacific Land (TPL) | Q1 2014 | 30.46% |
Cheniere Energy (LNG) | Q1 2014 | 29.72% |
Martin Marietta Materials (MLM) | Q1 2014 | 29.37% |
Zebra Technologies (ZBRA) | Q1 2014 | 28.92% |
First Solar (FSLR) | Q1 2014 | 28.57% |
Large-cap stocks are treated as having a market cap of $10B+.